{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/SPE/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-19T13:08:09.195Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":11053,"canonical_name":"SPECIAL OPPORTUNITIES FUND, INC.","cik":"0000897802","uei":null,"lei":null,"duns":null,"ticker":"SPE-PC"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":9},"count":9,"timeline":[{"ts":"2026-09-04","kind":"sec.filing","form_type":"N-CSRS","title":"N-CSRS — SPECIAL OPPORTUNITIES FUND, INC. — 2026-09-04","url_slug":"/sec/cik-0000897802/n-csrs/0001999371-26-019885","accession_number":"0001999371-26-019885","importance":30},{"ts":"2026-08-31","kind":"sec.filing","form_type":"NPORT-P","title":"NPORT-P — SPECIAL OPPORTUNITIES FUND, INC. — 2026-08-31","url_slug":"/sec/cik-0000897802/nport-p/0000910472-26-014189","accession_number":"0000910472-26-014189","importance":30},{"ts":"2026-08-20","kind":"sec.filing","form_type":"N-PX","title":"N-PX — SPECIAL OPPORTUNITIES FUND, INC. — 2026-08-20","url_slug":"/sec/cik-0000897802/n-px/0001580642-26-005491","accession_number":"0001580642-26-005491","importance":30},{"ts":"2026-06-11","kind":"sec.form144","reporter":"Focus Partners Wealth","title":"10% Stockholder","shares":1126,"usd_value":28015,"security_title":"Preferred Stock","approx_sale_date":"2026-06-11","accession_number":"0001959173-26-004557","importance":40.005602976},{"ts":"2026-06-03","kind":"sec.insider.s","reporter":"Dakos Andrew","title":"President and CEO","shares":5184,"price_per_share":14.11,"usd_value":73146,"security_title":"Common Stock","importance":35.07314624},{"ts":"2026-06-03","kind":"sec.insider.s","reporter":"Dakos Andrew","title":"President and CEO","shares":133,"price_per_share":14.07,"usd_value":1871,"security_title":"Common Stock","importance":35.00187131},{"ts":"2026-06-02","kind":"sec.form144","reporter":"Dakos Andrew","title":"Director","shares":null,"usd_value":null,"security_title":null,"approx_sale_date":null,"accession_number":"0001949846-26-000340","importance":40},{"ts":"2026-06-02","kind":"sec.insider.s","reporter":"Dakos Andrew","title":"President and CEO","shares":1077,"price_per_share":14.02,"usd_value":15100,"security_title":"Common Stock","importance":35.01509954},{"ts":"2026-06-01","kind":"sec.filing","form_type":"NPORT-P","title":"NPORT-P — SPECIAL OPPORTUNITIES FUND, INC. — 2026-06-01","url_slug":"/sec/cik-0000897802/nport-p/0000910472-26-008776","accession_number":"0000910472-26-008776","importance":30}]}